ClinicalTrials.Veeva

Menu

Gene Expression in Patients With Epiretinal Membranes

M

Medical University of Silesia

Status

Unknown

Conditions

Proliferative Diabetic Retinopathy

Study type

Observational

Funder types

Other

Identifiers

NCT01946451
SilesianMU

Details and patient eligibility

About

The purpose of this study was to investigate the expression of selected genes both in epiretinal membranes (ERMs) and peripheral blood mononuclear cells (PBMCs) from patients with primary and secondary epiretinal membranes in proliferative diabetic retinopathy. Possible correlations between messenger ribonucleic acid (mRNA) levels of these genes were also identified.

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Caucasian race,
  • both males and females,
  • aged ≥ 55 years,
  • suffering from idiopathic ERMs or secondary ERMs in proliferative diabetic retinopathy (PDR).
  • Presence of ERM was proven in optical coherence tomography (OCT) examination.

Exclusion criteria

  • aged < 55 years,
  • systemic connective tissue disease,
  • active inflammatory process

Trial design

0 participants in 2 patient groups

Idiophatic ERMs
Secondary ERMs

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems